A detailed history of Quest Partners LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 4,392 shares of FULC stock, worth $15,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,392
Previous 26,164 83.21%
Holding current value
$15,064
Previous $162 Million 90.33%
% of portfolio
0.0%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$3.18 - $9.74 $69,234 - $212,059
-21,772 Reduced 83.21%
4,392 $15.7 Million
Q2 2024

Aug 06, 2024

BUY
$5.98 - $9.31 $156,460 - $243,586
26,164 New
26,164 $162 Million

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $178M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.